We are live on ! Find out more
AGRX

Agile Therapeutics
AGRX

Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

79 hedge funds and large institutions have $107M invested in Agile Therapeutics in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more call options, than puts

Call options by funds: $1.53M | Put options by funds: $497K

136% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 14

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

74% more capital invested

Capital invested by funds: $61.4M → $107M (+$45.5M)

30% more funds holding

Funds holding: 61 → 79 (+18)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
79
Holders Change
+18
Holders Change %
+29.51%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
33
Increased
21
Reduced
10
Closed
14
Calls
$1.53M
Puts
$497K
Net Calls
+$1.04M
Net Calls Change
+$303K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$10.1M
2
State Street
State Street
Massachusetts
+$2.6M
3
Northern Trust
Northern Trust
Illinois
+$1.87M
4
DCM
DG Capital Management
New York
+$1.47M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.31M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$2.23M
2
Renaissance Technologies
Renaissance Technologies
New York
-$2.2M
3
Millennium Management
Millennium Management
New York
-$1.98M
4
EP
Eversept Partners
New York
-$1.32M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
$68.4K +$62.4K +12 New
LPL Financial
52
LPL Financial
California
$68K – – –
State Board of Administration of Florida Retirement System
53
State Board of Administration of Florida Retirement System
Florida
$67K +$62.4K +12 New
VOYA Investment Management
54
VOYA Investment Management
Georgia
$66K +$62.4K +12 New
RJA
55
Raymond James & Associates
Florida
$65K – – –
UBS Group
56
UBS Group
Switzerland
$61K +$57.2K +11 New
GC
57
Grimes & Company
Massachusetts
$59K +$5.2K +1 +10%
KM
58
Kalos Management
Georgia
$58K – – –
PP
59
Paloma Partners
Connecticut
$42K +$41.6K +8 New
CAN
60
Claraphi Advisory Network
United States
$40K +$36.4K +7 New
Prudential Financial
61
Prudential Financial
New Jersey
$37K +$36.4K +7 New
Victory Capital Management
62
Victory Capital Management
Texas
$31K -$20.8K -4 -40%
Legal & General Group
63
Legal & General Group
United Kingdom
$31K +$31.2K +6 New
Comerica Bank
64
Comerica Bank
Texas
$30K +$31.2K +6 New
AB
65
Amalgamated Bank
New York
$29K +$26K +5 New
CWM
66
Centric Wealth Management
Illinois
$28K – – –
ARTA
67
A.R.T. Advisors
New York
$28K +$26K +5 New
Bank of Montreal
68
Bank of Montreal
Ontario, Canada
$17K +$10.4K +2 +200%
AIP
69
Ameritas Investment Partners
Nebraska
$17K +$15.6K +3 New
IA
70
IFP Advisors
Florida
$14K – – –
US Bancorp
71
US Bancorp
Minnesota
$14K +$5.2K +1 +50%
TRCT
72
Tower Research Capital (TRC)
New York
$9K +$10.4K +2 New
BNP Paribas Financial Markets
73
BNP Paribas Financial Markets
France
$7.08K +$5.2K +1 New
Group One Trading
74
Group One Trading
Illinois
$7K -$229K -44 -98%
PFGIA
75
Patriot Financial Group Insurance Agency
Massachusetts
$7K – – –
1 2
3
4

AGRX Hedge Fund Activity: Q2 2020 in Review

79 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q2 2020, worth a combined $107M — up 74% from $61.4M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new AGRX positions and 14 closed out — a net gain of 19 holders — while 21 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $10.1M. The largest seller was OrbiMed, exiting entirely with an estimated $2.23M sold.

  • 79 institutional investors held Agile Therapeutics (AGRX) as of Q2 2020, up from 61 in Q1 2020.
  • Funds reported $107M of Agile Therapeutics stock for Q2 2020, up 74% quarter-over-quarter.
  • 33 funds opened new Agile Therapeutics positions in Q2 2020 and 14 closed out, a net change of +19 holders.
  • The largest Agile Therapeutics buyer in Q2 2020 was BlackRock, an estimated $10.1M added.
  • The largest Agile Therapeutics seller in Q2 2020 was OrbiMed, an estimated $2.23M sold.

Based on aggregated 13F filings for Q2 2020.